haloperidol has been researched along with clopenthixol in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (36.21) | 18.7374 |
| 1990's | 13 (22.41) | 18.2507 |
| 2000's | 14 (24.14) | 29.6817 |
| 2010's | 6 (10.34) | 24.3611 |
| 2020's | 4 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Elgen, K; Fuglum, E; Nygaard, HA | 1 |
| Eliander, H; Heikkilä, L; Pedersen, V; Turunen, M; Vartiainen, H | 1 |
| Koskinen, T; Mølbjerg, C; Nerdrum, T; Pedersen, V; Thelander, S; Wistedt, B | 1 |
| Gerlach, J; Hagert, U; Lublin, H; Meidahl, B; Mølbjerg, C; Pedersen, V; Rendtorff, C; Tolvanen, E | 1 |
| Kemperman, CJ; van den Hoofdakker, RH | 1 |
| Allerup, P; Bolwig, TG; Glenthøj, B; Hemmingsen, R | 1 |
| Andersen, JB; Belstad, BE; Elgen, K; Fuglum, E; Jensen, D; Müller, F; Müller, KJ; Schillinger, A; Schulstad, B | 1 |
| Knudsen, P | 1 |
| Zetler, G | 1 |
| Hyttel, J | 1 |
| Achté, KA; Turunen, S | 1 |
| Hertrich, O | 1 |
| Nielsen, IM | 1 |
| Clark, ML; Collins, S; Serafetinides, EA | 1 |
| Clark, ML; Serafetinides, EA; Willis, D | 1 |
| Clark, ML; Serafetinides, EA | 1 |
| Serafetinides, EA | 1 |
| Serafetinides, EA; Willis, D | 1 |
| Boeck, V; Christensen, AV; Fjalland, B; Franck, KF; Nielsen, IM; Nymark, M; Pedersen, V | 1 |
| Harder, A; Modestin, J; Steiner, H | 1 |
| Svendsen, O | 1 |
| Fritze, J | 1 |
| Heikkilä, L; Laitinen, J; Vartiainen, H | 1 |
| Karsten, D; Kivimäki, T; Linna, SL; Pollari, L; Turunen, S | 1 |
| Götestam, KG; Ljunghall, S; Olsson, B | 1 |
| Bache, T; Maehlum, E; Malt, UF; Noren, O; Nystad, R; Sjaastad, M; Solberg, KO; Tønseth, S; Zachariassen, P | 1 |
| Beauclair, L; Chouinard, G; Safadi, G | 1 |
| Hamlin, GW; Ormerod, LP; Parry, AK; Saleem, PT | 1 |
| Bucci, P; Galderisi, S; Kemali, D; Maj, M; Mucci, A | 1 |
| Alhfors, UG; Baastrup, PC; Bjerkenstedt, L; Brekke, B; Dencker, SJ; Elgen, K; Fensbo, C; Fredslund-Andersen, K; Gravem, A; Pedersen, V | 1 |
| Bertilsson, L; Dahl, ML; Ekqvist, B; Llerena, A | 1 |
| Chandramohan, P; Cheah, YC; Chin, CN; Hamid, AR; Leonard, AO; Loh, CC; Mahmud, M; Norhamidah, MS; Philip, G; Ramlee, T; Roslan, KA; Suraya, Y; Zakariah, MS; Zulkifli, G | 1 |
| Angelo, HR; Petersen, A | 1 |
| Al-Sughayir, MA | 1 |
| Baastrup, PC; Bech, P; de Bleeker, E; Ropert, R | 1 |
| Ferrier, IN; McAllister-Williams, RH | 1 |
| Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M | 1 |
| Kuasirikul, S; Taymeeyapradit, U | 1 |
| VOTAVA, Z | 1 |
| AMDISEN, A; JENSEN, K | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Barna, I; Gazdag, G; Iványi, Z; Tolna, J | 1 |
| Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD | 1 |
| Perquin, LN | 1 |
| Glick, ID; Schreiner, A; Shkedy, Z | 1 |
| Fick, L; Fuller, A; Mitchell, D | 1 |
| Castle, DJ; Isik, T; Karagianis, J; Kim, CY; Melamed, Y; Omar, AN; Pidrman, V; Rosales, JI; Sarosi, A; Treuer, T; Udristoiu, T | 1 |
| Bramness, JG; Gjerden, P; Slørdal, L | 1 |
| Gibson, RC; Gunadasa, S; Jayakody, K; Kumar, A | 1 |
| Adams, CE; Jones, H; Powney, MJ | 1 |
| Eleméry, M; Faludi, G; Kovács, G; Szegő, A | 1 |
| Bernard, S; Hugo, N; Kristof, M; Lisbeth, P; Manuel, M; Vincent, H | 1 |
| Hall, K; Lewitt, M; Melkersson, K | 1 |
| Høiseth, G; Solhaug, V; Waade, RB | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Bloemhof-Bris, E; Shelef, A; Sinai, O; Stryjer, R; Weizman, S | 1 |
| Osman, E; Yıldız, M | 1 |
7 review(s) available for haloperidol and clopenthixol
| Article | Year |
|---|---|
Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clopenthixol; Double-Blind Method; Female; Haloperidol; Homes for the Aged; Humans; Male; Meta-Analysis as Topic; Methotrimeprazine; Norway; Nursing Homes; Severity of Illness Index; Tranquilizing Agents | 1992 |
Disposition of the neuroleptics perphenazine, zuclopenthixol, and haloperidol cosegregates with polymorphic debrisoquine hydroxylation.
Topics: Antipsychotic Agents; Clopenthixol; Debrisoquin; Haloperidol; Humans; Hydroxylation; Perphenazine; Polymorphism, Genetic | 1993 |
Rapid tranquillisation: time for a reappraisal of options for parenteral therapy.
Topics: Acute Disease; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Death, Sudden; Droperidol; Drug Therapy, Combination; Haloperidol; Humans; Injections, Intramuscular; Injections, Intravenous; Psychotic Disorders | 2002 |
[NEW FINDINGS IN RESEARCH ON PSYCHOPHARMACOLOGY].
Topics: Amitriptyline; Chlordiazepoxide; Chlorprothixene; Clopenthixol; Haloperidol; Humans; Imipramine; Phenothiazines; Propylene Glycols; Psychopharmacology; Reserpine; Thiazines; Tranquilizing Agents | 1963 |
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dibenzothiazepines; Haloperidol; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Violence | 2012 |
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles | 2012 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
22 trial(s) available for haloperidol and clopenthixol
| Article | Year |
|---|---|
Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clopenthixol; Double-Blind Method; Female; Haloperidol; Homes for the Aged; Humans; Male; Meta-Analysis as Topic; Methotrimeprazine; Norway; Nursing Homes; Severity of Illness Index; Tranquilizing Agents | 1992 |
Zuclopenthixol and haloperidol in patients with acute psychotic states. A double-blind, multi-centre study.
Topics: Adult; Aged; Biperiden; Clopenthixol; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Psychotic Disorders; Severity of Illness Index; Treatment Outcome | 1992 |
Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors | 1991 |
Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia.
Topics: Adult; Aged; Clopenthixol; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders | 1991 |
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Mental Disorders; Methotrimeprazine; Multicenter Studies as Topic; Random Allocation; Thioxanthenes | 1989 |
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Bilirubin; Blood Cell Count; Blood Pressure; Blood Urea Nitrogen; Body Temperature; Body Weight; Chemical and Drug Induced Liver Injury; Chlorpromazine; Cholesterol; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Extrapyramidal Tracts; Female; Haloperidol; Hematocrit; Humans; Liver; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychological Tests; Schizophrenia; Tranquilizing Agents; Xanthenes | 1972 |
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Electroencephalography; Evaluation Studies as Topic; Female; Haloperidol; Humans; Male; Middle Aged; Placebos; Schizophrenia; Tranquilizing Agents | 1972 |
Psychological effects of single-dose antipsychotic medication.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Motor Skills; Piperazines; Placebos; Psychological Tests; Schizophrenia; Thioxanthenes; Tranquilizing Agents; Xanthenes | 1973 |
A method of quantifying EEG for psychopharmacological research.
Topics: Alpha Rhythm; Chlorpromazine; Clopenthixol; Electroencephalography; Haloperidol; Humans; Methods; Molindone; Placebos; Psychiatric Status Rating Scales; Psychopharmacology; Research; Schizophrenia | 1973 |
Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
Topics: Adult; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Stereoisomerism; Thinking; Thioxanthenes | 1981 |
Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.
Topics: Adult; Behavior; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Intellectual Disability; Male; Middle Aged; Psychiatric Status Rating Scales; Stereoisomerism; Thioxanthenes | 1981 |
A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.
Topics: Aged; Clinical Trials as Topic; Clopenthixol; Dementia; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Stereoisomerism; Thioxanthenes | 1981 |
Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients.
Topics: Adult; Behavior Therapy; Clopenthixol; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Intellectual Disability; Learning Disabilities; Male; Middle Aged; Single-Blind Method; Social Behavior Disorders; Treatment Outcome | 1995 |
A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Arousal; Clopenthixol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis.
Topics: Acute Disease; Adult; Analysis of Variance; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Female; Haloperidol; Humans; Male; Middle Aged; Oils; Psychiatric Status Rating Scales; Psychotic Disorders | 1993 |
A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1998 |
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2002 |
Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients.
Topics: Acute Disease; Adult; Brief Psychiatric Rating Scale; Clopenthixol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Linear Models; Male; Probability; Psychotic Disorders; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2002 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Perphenazine; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
Long-acting neuroleptics used in wildlife management do not impair thermoregulation or physical activity in goats (Capra hircus).
Topics: Animals; Animals, Wild; Antipsychotic Agents; Body Temperature Regulation; Clopenthixol; Goats; Haloperidol; Male; Motor Activity; Perphenazine; Time Factors; Veterinary Drugs | 2007 |
Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Clopenthixol; Cytochrome P-450 CYP2D6; Drug Monitoring; Drug Therapy, Combination; Female; Genotype; Haloperidol; Humans; Male; Middle Aged; Paliperidone Palmitate; Young Adult | 2016 |
30 other study(ies) available for haloperidol and clopenthixol
| Article | Year |
|---|---|
Neuroleptic malignant syndrome (NMS): challenge with zuclopenthixol and follow-up--a case report.
Topics: Adult; Clopenthixol; Dyskinesia, Drug-Induced; Electroencephalography; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Psychiatric Status Rating Scales; Psychotic Disorders; Trifluoperazine | 1990 |
Intermittent versus continuous neuroleptic treatment in a rat model.
Topics: Animals; Behavior, Animal; Clopenthixol; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Random Allocation; Rats; Rats, Inbred Strains | 1990 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Effect of prolonged treatment with neuroleptics on dopamine D-1 and D-2 receptor density in corpus striatum of mice.
Topics: Animals; Antipsychotic Agents; Benzazepines; Clopenthixol; Corpus Striatum; Haloperidol; Male; Mice; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone | 1986 |
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Haloperidol; Humans; Male; Mastication; Middle Aged; Movement Disorders; Parkinson Disease; Perphenazine; Phenothiazines; Reserpine; Thioridazine; Tongue; Tranquilizing Agents | 1967 |
[Psychopharmacological therapy. 2. Neuroleptic agents].
Topics: Chemical Phenomena; Chemistry; Clopenthixol; Ethanol; Fluphenazine; Haloperidol; Humans; Models, Structural; Phenothiazines; Piperazines; Reserpine; Thiazines; Tranquilizing Agents; Xanthines | 1972 |
Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Clopenthixol; Dogs; Drug Evaluation, Preclinical; Drug Tolerance; Flupenthixol; Fluphenazine; Haloperidol; Mice; Motor Activity; Perphenazine; Rats; Tranquilizing Agents | 1974 |
Voltage laterality in the EEG of psychiatric patients.
Topics: Adult; Brain; Chlorpromazine; Clopenthixol; Dominance, Cerebral; Dose-Response Relationship, Drug; Electroencephalography; Female; Functional Laterality; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Tranquilizing Agents | 1973 |
The comparative pharmacology of flupenthixol and some reference neuroleptics.
Topics: Animals; Avoidance Learning; Behavior, Animal; Body Temperature; Cats; Chlorpromazine; Chlorprothixene; Clopenthixol; Conditioning, Operant; Dogs; Drug Evaluation, Preclinical; Ethanol; Female; Fluphenazine; Guinea Pigs; Haloperidol; Isomerism; Male; Mice; Nictitating Membrane; Norepinephrine; Perphenazine; Piperazines; Rabbits; Rats; Structure-Activity Relationship; Tranquilizing Agents | 1973 |
[Course of body temperature during injection therapy with neuroleptics. Statistical evaluation of data from a retrospective study].
Topics: Body Temperature; Chlorpromazine; Chlorprothixene; Clopenthixol; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Humans; Mental Disorders; Methotrimeprazine; Parasympatholytics; Piperazines; Retrospective Studies; Schizophrenia; Tranquilizing Agents; Xanthines | 1971 |
Local muscle damage and oily vehicles: a study on local reactions in rabbits after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Clopenthixol; Female; Haloperidol; Injections, Intramuscular; Male; Muscular Diseases; Oils; Pharmaceutical Vehicles; Rabbits | 1983 |
Can neuroleptics influence the function of the brain hemispheres asymmetrically?
Topics: Animals; Antipsychotic Agents; Brain; Carotid Arteries; Clopenthixol; Dystonia; Flupenthixol; Functional Laterality; Haloperidol; Injections, Intra-Arterial; Male; Posture; Rats; Rats, Inbred Strains; Reserpine; Stereoisomerism | 1984 |
Recurrent sinus arrest in association with neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Cardiac Pacing, Artificial; Catatonia; Chlorpromazine; Clopenthixol; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Heart Arrest; Humans; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizophrenia | 1994 |
QEEG alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients.
Topics: Adolescent; Adult; Brain; Clopenthixol; Dose-Response Relationship, Drug; Electroencephalography; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 1994 |
Therapeutic drug monitoring of haloperidol, perphenazine, and zuclopenthixol in serum by a fully automated sequential solid phase extraction followed by high-performance liquid chromatography.
Topics: Antipsychotic Agents; Autoanalysis; Calibration; Chromatography, High Pressure Liquid; Clopenthixol; Haloperidol; Humans; Perphenazine; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2001 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utilization; Female; Flupenthixol; Fluphenazine; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Saudi Arabia; Surveys and Questionnaires | 2000 |
Dimensionality, responsiveness and standardization of the Bech-Rafaelsen Mania Scale in the ultra-short therapy with antipsychotics in patients with severe manic episodes.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clopenthixol; Female; Haloperidol; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Reference Standards; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2001 |
TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.
Topics: Clopenthixol; Double-Blind Method; Drug Therapy; Extrapyramidal Tracts; Haloperidol; Humans; Orphenadrine; Parasympatholytics; Parkinsonian Disorders; Perphenazine; Placebos; Tranquilizing Agents | 1964 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride | 2004 |
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome | 2005 |
Treatment with the new antipsychotic sertindole for late-occurring undesirable movement effects.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Middle Aged; Schizophrenia; Time Factors | 2005 |
Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clopenthixol; Cross-Cultural Comparison; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Male; Olanzapine; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2009 |
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Chlorprothixene; Cholinergic Antagonists; Clopenthixol; Clozapine; Drug Prescriptions; Female; Follow-Up Studies; Haloperidol; Humans; Logistic Models; Male; Methotrimeprazine; Middle Aged; Mortality; Norway; Odds Ratio; Piperazines; Registries; Thiazoles | 2010 |
[Emergency psychopharmacotherapy in Hungary -- preliminary data].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clopenthixol; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Treatment; Female; Haloperidol; Humans; Hungary; Male; Middle Aged; Olanzapine; Piperazines; Practice Patterns, Physicians'; Promethazine; Psychiatry; Psychomotor Agitation; Psychotic Disorders; Quinolones; Surveys and Questionnaires | 2014 |
Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Topics: Adult; Amino Acids; Antipsychotic Agents; Chromatography, Ion Exchange; Clopenthixol; Clozapine; Cohort Studies; Female; Glutamic Acid; Haloperidol; Humans; Insulin Resistance; Male; Middle Aged; Perphenazine; Prospective Studies; Psychotic Disorders; Schizophrenia; Thioridazine; Tyrosine | 2015 |
Impact of CYP2D6 on serum concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol.
Topics: Clopenthixol; Cytochrome P-450 CYP2D6; Flupenthixol; Genotype; Haloperidol; Humans; Perphenazine; Retrospective Studies | 2021 |
Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscular.
Topics: Antipsychotic Agents; Benzodiazepines; Clopenthixol; Haloperidol; Humans; Injections, Intramuscular; Olanzapine; Psychomotor Agitation; Psychotic Disorders | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |